Clinical trial

Naturalistic Study of Ketamine in the Treatment of Depression

Hospital de Clinicas de Porto AlegreUnknownStarted May 1, 202190 enrolledBrazilNCT05249309

Abstract

This study aims to examine the effect of ketamine in decreasing the risk of suicide in patients with depression and its effectiveness as an antidepressant agent.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

SuicideMajor depressive disorderMajor depressionUnipolar depressionDepressive disordersBipolar I disorderBipolar II disorderBipolar depressionMajor Depressive DisorderBipolar DisorderBipolar DepressionBipolar I DisorderBipolar II DisorderAffective Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Pharmacologic Approaches to Suicide Prevention.

Zisook S, Domingues I, Compton J

Europe PMC2023

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025